207 related articles for article (PubMed ID: 37820088)
21. Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.
Jaspan T; Morgan PS; Warmuth-Metz M; Sanchez Aliaga E; Warren D; Calmon R; Grill J; Hargrave D; Garcia J; Zahlmann G
AJNR Am J Neuroradiol; 2016 Sep; 37(9):1581-7. PubMed ID: 27127006
[TBL] [Abstract][Full Text] [Related]
22. Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy.
Graham MS; Mellinghoff IK
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003625
[TBL] [Abstract][Full Text] [Related]
23. Strategies to target drugs to gliomas and CNS metastases of solid tumors.
Milojkovic Kerklaan B; van Tellingen O; Huitema AD; Beijnen JH; Boogerd W; Schellens JH; Brandsma D
J Neurol; 2016 Mar; 263(3):428-40. PubMed ID: 26477024
[TBL] [Abstract][Full Text] [Related]
24. Malignant gliomas: new translational therapies.
Sul J; Fine HA
Mt Sinai J Med; 2010; 77(6):655-66. PubMed ID: 21105127
[TBL] [Abstract][Full Text] [Related]
25. CNS Anticancer Drug Discovery and Development Conference White Paper.
Levin VA; Tonge PJ; Gallo JM; Birtwistle MR; Dar AC; Iavarone A; Paddison PJ; Heffron TP; Elmquist WF; Lachowicz JE; Johnson TW; White FM; Sul J; Smith QR; Shen W; Sarkaria JN; Samala R; Wen PY; Berry DA; Petter RC
Neuro Oncol; 2015 Nov; 17 Suppl 6(Suppl 6):vi1-26. PubMed ID: 26403167
[TBL] [Abstract][Full Text] [Related]
26. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
27. T lymphocyte-targeted immune checkpoint modulation in glioma.
Kelly WJ; Giles AJ; Gilbert M
J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32051289
[TBL] [Abstract][Full Text] [Related]
28. Molecular pathogenesis and therapeutic implications in pediatric high-grade gliomas.
Juratli TA; Qin N; Cahill DP; Filbin MG
Pharmacol Ther; 2018 Feb; 182():70-79. PubMed ID: 28830841
[TBL] [Abstract][Full Text] [Related]
29. Novel therapeutic delivery approaches in development for pediatric gliomas.
Warren KE
CNS Oncol; 2013 Sep; 2(5):427-35. PubMed ID: 24511389
[TBL] [Abstract][Full Text] [Related]
30. Mutations in chromatin machinery and pediatric high-grade glioma.
Lulla RR; Saratsis AM; Hashizume R
Sci Adv; 2016 Mar; 2(3):e1501354. PubMed ID: 27034984
[TBL] [Abstract][Full Text] [Related]
31. [Chemotherapy of brain tumors].
Kuratsu J; Ushio Y
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():377-83. PubMed ID: 7986118
[TBL] [Abstract][Full Text] [Related]
32. The Plant-Derived Compound Resveratrol in Brain Cancer: A Review.
Kiskova T; Kubatka P; Büsselberg D; Kassayova M
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963897
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development.
Garcia-Fabiani MB; Ventosa M; Comba A; Candolfi M; Nicola Candia AJ; Alghamri MS; Kadiyala P; Carney S; Faisal SM; Schwendeman A; Moon JJ; Scheetz L; Lahann J; Mauser A; Lowenstein PR; Castro MG
Expert Opin Investig Drugs; 2020 Jul; 29(7):659-684. PubMed ID: 32400216
[TBL] [Abstract][Full Text] [Related]
34. Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy.
Moody TW; Lee L; Ramos-Alvarez I; Iordanskaia T; Mantey SA; Jensen RT
Front Endocrinol (Lausanne); 2021; 12():728088. PubMed ID: 34539578
[TBL] [Abstract][Full Text] [Related]
35. Alphaxalone inhibits growth, migration and invasion of rat C6 malignant glioma cells.
Sun H; Zheng X; Zhou Y; Zhu W; Ou Y; Shu M; Gao X; Leng T; Qiu P; Yan G
Steroids; 2013 Oct; 78(10):1041-5. PubMed ID: 23831782
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide synthase inhibitors as potential therapeutic agents for gliomas: A systematic review.
Merenzon MA; Hincapie Arias E; Bhatia S; Shah AH; Higgins DMO; Villaverde M; Belgorosky D; Eijan AM
Nitric Oxide; 2023 Sep; 138-139():10-16. PubMed ID: 37279819
[TBL] [Abstract][Full Text] [Related]
37. Cerebral microdialysis in glioma studies, from theory to application.
Liu L; Zhang X; Lou Y; Rao Y; Zhang X
J Pharm Biomed Anal; 2014 Aug; 96():77-89. PubMed ID: 24747145
[TBL] [Abstract][Full Text] [Related]
38. Modeling phenotypes of malignant gliomas.
Sampetrean O; Saya H
Cancer Sci; 2018 Jan; 109(1):6-14. PubMed ID: 28796931
[TBL] [Abstract][Full Text] [Related]
39. Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top".
Simonelli M; Persico P; Perrino M; Zucali PA; Navarria P; Pessina F; Scorsetti M; Bello L; Santoro A
Cancer Treat Rev; 2018 Sep; 69():121-131. PubMed ID: 29966936
[TBL] [Abstract][Full Text] [Related]
40. Brain Tumor Networks in Diffuse Glioma.
Yang Y; Schubert MC; Kuner T; Wick W; Winkler F; Venkataramani V
Neurotherapeutics; 2022 Oct; 19(6):1832-1843. PubMed ID: 36357661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
